Stephanie Schorge: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 01:11, 18 March 2025
Stephanie Schorge is a renowned neuroscientist and pharmacologist known for her significant contributions to the field of epilepsy research. She is currently a professor at the University College London (UCL), where she leads a team of researchers in the Schorge Lab.
Early Life and Education[edit]
Stephanie Schorge was born and raised in United States. She completed her undergraduate studies in Biology and Chemistry at the University of California, Berkeley. She then pursued her PhD in Pharmacology at the University of California, San Francisco (UCSF), where she focused on the study of ion channels and their role in neurological disorders.
Career[edit]
After completing her PhD, Schorge moved to the United Kingdom to join the University College London as a postdoctoral researcher. She later became a faculty member and established the Schorge Lab, which focuses on understanding the molecular mechanisms underlying epilepsy.
Her research primarily involves the study of GABA receptors, which are a type of ion channel that plays a crucial role in the functioning of the nervous system. Schorge and her team are particularly interested in how changes in these receptors can lead to the development of epilepsy.
Contributions to Epilepsy Research[edit]
Schorge's work has significantly advanced our understanding of the molecular mechanisms underlying epilepsy. Her research has shown that changes in the structure and function of GABA receptors can lead to the development of this disorder. This has opened up new avenues for the development of more effective treatments for epilepsy.
Awards and Recognition[edit]
In recognition of her contributions to neuroscience and pharmacology, Schorge has received numerous awards and honors. These include the British Pharmacological Society's Award for Outstanding Contributions to Pharmacology and the Royal Society's Wolfson Research Merit Award.
See Also[edit]
